NO20006088D0 - Fremgangsmåter for å öke nivåer av acetylcholin - Google Patents

Fremgangsmåter for å öke nivåer av acetylcholin

Info

Publication number
NO20006088D0
NO20006088D0 NO20006088A NO20006088A NO20006088D0 NO 20006088 D0 NO20006088 D0 NO 20006088D0 NO 20006088 A NO20006088 A NO 20006088A NO 20006088 A NO20006088 A NO 20006088A NO 20006088 D0 NO20006088 D0 NO 20006088D0
Authority
NO
Norway
Prior art keywords
acetylcholine
methods
increase levels
levels
increase
Prior art date
Application number
NO20006088A
Other languages
English (en)
Other versions
NO20006088L (no
Inventor
Henry Uhlman Bryant
Michele Anette Glinn
Steven Mark Paus
Xin Wu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20006088L publication Critical patent/NO20006088L/no
Publication of NO20006088D0 publication Critical patent/NO20006088D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006088A 1998-06-16 2000-11-30 Fremgangsmåter for å öke nivåer av acetylcholin NO20006088D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8948898P 1998-06-16 1998-06-16
PCT/US1999/012603 WO1999065309A1 (en) 1998-06-16 1999-06-04 Methods for increasing levels of acetylcholine

Publications (2)

Publication Number Publication Date
NO20006088L NO20006088L (no) 2000-11-30
NO20006088D0 true NO20006088D0 (no) 2000-11-30

Family

ID=22217922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006088A NO20006088D0 (no) 1998-06-16 2000-11-30 Fremgangsmåter for å öke nivåer av acetylcholin

Country Status (17)

Country Link
EP (1) EP0966964A1 (no)
JP (1) JP2002518299A (no)
KR (1) KR20010052892A (no)
CN (1) CN1305343A (no)
AU (1) AU748659B2 (no)
BR (1) BR9911217A (no)
CA (1) CA2333453A1 (no)
HR (1) HRP20000861A2 (no)
HU (1) HUP0103834A2 (no)
IL (1) IL138914A0 (no)
NO (1) NO20006088D0 (no)
PL (1) PL346242A1 (no)
SK (1) SK18812000A3 (no)
TR (1) TR200003714T2 (no)
TW (1) TW486367B (no)
WO (1) WO1999065309A1 (no)
ZA (1) ZA200005885B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
JP2002518329A (ja) 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー アセチルコリンレベルを増加させる方法
KR101226702B1 (ko) * 2010-10-08 2013-01-25 충북대학교 산학협력단 인간 콜린 아세틸트랜스퍼라아제를 발현하는 인간 신경줄기세포 및 이의 용도
KR102117741B1 (ko) * 2017-12-31 2020-06-01 롯데첨단소재(주) 도금용 열가소성 수지 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09507071A (ja) * 1993-12-21 1997-07-15 イーライ・リリー・アンド・カンパニー アミロイド原性ペプチドに関連した状態を治療又は予防する方法
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
AR003930A1 (es) * 1995-02-28 1998-09-30 Lilly Co Eli Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
ES2188946T3 (es) * 1996-06-07 2003-07-01 Eisai Co Ltd Polimorfos de clorhidrato de donepecil y proceso de fabricacion de los mismos.
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.

Also Published As

Publication number Publication date
BR9911217A (pt) 2001-03-06
PL346242A1 (en) 2002-01-28
TR200003714T2 (tr) 2001-07-23
TW486367B (en) 2002-05-11
EP0966964A1 (en) 1999-12-29
JP2002518299A (ja) 2002-06-25
NO20006088L (no) 2000-11-30
AU4819199A (en) 2000-01-05
HUP0103834A2 (hu) 2002-05-29
IL138914A0 (en) 2001-11-25
ZA200005885B (en) 2001-10-22
HRP20000861A2 (en) 2001-10-31
WO1999065309A1 (en) 1999-12-23
KR20010052892A (ko) 2001-06-25
AU748659B2 (en) 2002-06-06
CN1305343A (zh) 2001-07-25
SK18812000A3 (sk) 2002-01-07
CA2333453A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
NO20010050L (no) Fremgangsmåte for å forbedre söthetsavlevering av sukralose
NO20011509L (no) Innretning for å forenkle tilkopling av rör ved bruk av toppdrift
NO996510D0 (no) Fremgangsmåte for å tilveiebringe avkjoeling
NO20012940L (no) Fremgangsmåter og sammensetninger for å redusere permeabilitetene til underjordiske soner
IS5462A (is) Setin 4-amínó-þíazol-2-yl efnasambönd sem hindrarfyrir CDK
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
NO20012691D0 (no) Isomerisering av hydrokarboner
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
NO20010899L (no) Forbedring av ugunstige apomorfin-effekter
NO991360L (no) FremgangsmÕte for omdannelse av hydrokarbonoljer
NO976150D0 (no) Fremgangsmåte for å forbedre overföringen av en forbindelse fra en SGSN til en annen SGSN
NO985384D0 (no) FremgangsmÕte for fremstilling av bitumensammensetninger
NO941416L (no) Fremgangsmåte for å bestemme vanndybden
ID25901A (id) Proses pembuatan 4-aminometil-pirolidin-3-on terlindung
FI963868L (fi) Bitumikoostumuksia
NO963888D0 (no) Innretning for å begrense fordamping av vann
ID15897A (id) Proses distilasi
NO20006087D0 (no) Fremgangsmåter for å öke nivåer av acetylcholin
DE69926169D1 (de) Fernnebensprechkompensation
EA200001241A1 (ru) Способ доступа к ресурсам всемирной паутины
NO20002435D0 (no) Anvendelse av ketolider for forebyggelse av trombotiske komplikasjoner relatert til aterosklerose
DK0978615T3 (da) Dør til køretøj
NO973609D0 (no) Fremgangsmåte for å inhibere effektene av IL-6
NO20005322L (no) Fremgangsmåte for å öke effektiviteten av handel
IL138914A0 (en) Methods for increasing levels of acetylcholine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application